Chapter 3. Outcome and Adverse Effect Measures in Neurology

  1. Livia Candelise1,
  2. Richard Hughes2,
  3. Alessandro Liberati3,
  4. Bernard M.J. Uitdehaag4 and
  5. Charles Warlow5
  1. Jorge G. Burneo and
  2. Samuel Wiebe

Published Online: 12 NOV 2007

DOI: 10.1002/9780470988350.ch3

Evidence-based Neurology: Management of Neurological Disorders

Evidence-based Neurology: Management of Neurological Disorders

How to Cite

Burneo, J. G. and Wiebe, S. (2007) Outcome and Adverse Effect Measures in Neurology, in Evidence-based Neurology: Management of Neurological Disorders (eds L. Candelise, R. Hughes, A. Liberati, B. M.J. Uitdehaag and C. Warlow), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470988350.ch3

Editor Information

  1. 1

    Cochrane Neurological Network, Ospedale Magglore Policlinico, University of Milan, Italy

  2. 2

    King's College London School of Medicine at Guy's, King's College and St Thomas' Hospitals, London, UK

  3. 3

    Università di Modena e Reggio Emillia, Modena, Italy

  4. 4

    VU University Medical Center, Amsterdam, The Netherlands

  5. 5

    University of Edinburgh, Western General Hospital, Edinburgh, UK

Publication History

  1. Published Online: 12 NOV 2007
  2. Published Print: 1 JAN 2007

ISBN Information

Print ISBN: 9780727918116

Online ISBN: 9780470988350

SEARCH

Keywords:

  • good outcome measure;
  • primary and secondary outcomes;
  • placebos and blinding;
  • quality of life QOL;
  • likelihood of being helped versus harmed (LHH)

Summary

This chapter contains sections titled:

  • Measuring outcomes

  • Applying outcome measures in clinical practice

  • Measuring adverse effects

  • Illustrating outcomes measures with an example: Epilepsy